Strattera Cleared For Longer Use In ADHD Kids
This article was originally published in The Pink Sheet Daily
Trial data could reassure doctors about treating as needed, Lilly says.
You may also be interested in...
British biopharma had pegged nearly one-third of drug’s sales to off-label adult usage.
Shire plans to launch its nonstimulant ADHD candidate Intuniv in the second half of 2009, though new studies may be required to gain FDA approval
Data analysis used as the basis for a public health advisory on Lilly’s Strattera in children and adolescents is unreliable, SUNY Upstate Medical University, Columbia University professors say.